Sprint Bioscience (Sweden) Probability of Future Stock Price Finishing Under 14.0
| SPRINT Stock | SEK 1.36 0.06 4.62% |
Sprint |
Sprint Bioscience Target Price Odds to finish below 14.0
The tendency of Sprint Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under kr 14.00 after 90 days |
| 1.36 | 90 days | 14.00 | close to 99 |
Based on a normal probability distribution, the odds of Sprint Bioscience to stay under kr 14.00 after 90 days from now is close to 99 (This Sprint Bioscience AB probability density function shows the probability of Sprint Stock to fall within a particular range of prices over 90 days) . Probability of Sprint Bioscience price to stay between its current price of kr 1.36 and kr 14.00 at the end of the 90-day period is about 1.64 .
Assuming the 90 days trading horizon Sprint Bioscience AB has a beta of -0.45. This usually implies as returns on the benchmark increase, returns on holding Sprint Bioscience are expected to decrease at a much lower rate. During a bear market, however, Sprint Bioscience AB is likely to outperform the market. Additionally Sprint Bioscience AB has an alpha of 0.6355, implying that it can generate a 0.64 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Sprint Bioscience Price Density |
| Price |
Predictive Modules for Sprint Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sprint Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sprint Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sprint Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sprint Bioscience is not an exception. The market had few large corrections towards the Sprint Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sprint Bioscience AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sprint Bioscience within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.64 | |
β | Beta against NYSE Composite | -0.45 | |
σ | Overall volatility | 0.15 | |
Ir | Information ratio | 0.08 |
Sprint Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sprint Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sprint Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sprint Bioscience is way too risky over 90 days horizon | |
| Sprint Bioscience may become a speculative penny stock | |
| Sprint Bioscience appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 35.11 M. Net Loss for the year was (25.08 M) with profit before overhead, payroll, taxes, and interest of 24.59 M. | |
| Sprint Bioscience AB has accumulated about 13.82 M in cash with (40.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19. | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders |
Sprint Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sprint Stock often depends not only on the future outlook of the current and potential Sprint Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sprint Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 70.6 M |
Sprint Bioscience Technical Analysis
Sprint Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Sprint Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sprint Bioscience AB. In general, you should focus on analyzing Sprint Stock price patterns and their correlations with different microeconomic environments and drivers.
Sprint Bioscience Predictive Forecast Models
Sprint Bioscience's time-series forecasting models is one of many Sprint Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sprint Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sprint Bioscience
Checking the ongoing alerts about Sprint Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sprint Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sprint Bioscience is way too risky over 90 days horizon | |
| Sprint Bioscience may become a speculative penny stock | |
| Sprint Bioscience appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 35.11 M. Net Loss for the year was (25.08 M) with profit before overhead, payroll, taxes, and interest of 24.59 M. | |
| Sprint Bioscience AB has accumulated about 13.82 M in cash with (40.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19. | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders |
Check out Sprint Bioscience Backtesting, Sprint Bioscience Valuation, Sprint Bioscience Correlation, Sprint Bioscience Hype Analysis, Sprint Bioscience Volatility, Sprint Bioscience History as well as Sprint Bioscience Performance. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |